The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial

References

• Chinese Guidelines for Prevention and Treatment of Hypertension. (reviseded 2010). Chin J Hypertens 2011;19:701–42
   Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC). J Hypertens 2007;25:1105–87
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 Report. J Am Med Assoc 2003;289:2560–72
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-does combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713–19
   PubMed Web of Science ®Google Scholar
• Sun JX, Cipriano A, Chan K, John VA. Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects. Eur J Clin Pharmacol 1994;47:285–9
   PubMed Web of Science ®Google Scholar
• Frishman WH, Ram CVS, McMahon FG, et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol 1995;35:1060–6
   PubMed Web of Science ®Google Scholar
• Kuschnir E, Acuna E, Sevilla D. Treatment of patients with essential hypertension: amlodipine 5mg/benazepril 20mg compared with amlodipine 5 mg, benazepril 20mg, and placebo. Clin Ther 1996;18:1213–24
   PubMed Web of Science ®Google Scholar
• Pool J, Kaihlanen P, Lewis G, et al. Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. J Hum Hypertens 2001;15:495–8
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. Effect of angiotensin-converting-enzyme inhibitors, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators N Engl J Med 2000;342:145–53
   Google Scholar
• Julius S, Kjeldsen SE, Weber M, et al; VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the value randomized trial. Lancet 2004;363:2022–31
   PubMed Web of Science ®Google Scholar
• Cook NR, Cohen J, Hebert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995;155:701–9
   PubMed Web of Science ®Google Scholar
• Liu LS. Cardiovascular disease in China. Biochem Cell Biol 2007;85:157–63
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al. ACCOMPLISH Trial Investigators et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417–28
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005;366:895–906
   PubMed Web of Science ®Google Scholar
• Tatti P, Pahor M, Byington RP, et al. Outcomes results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597–603
   PubMed Web of Science ®Google Scholar
• Rothwell PM. Limitations of the usual blood pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010;375:938–48
   PubMed Web of Science ®Google Scholar
• Neutel LM. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. J Hum Hypertens 2004;18:599–606
   PubMed Web of Science ®Google Scholar
• Neutel JM, Smith DH, Weber MA. Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass. Am J Hypertens 2004;17:37–42
   PubMed Web of Science ®Google Scholar
• Winer N, Folker A, Murphy JA, et al. Effect of fixed-dose ACE-inhibitors/calcium channel blocker combination therapy vs ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes. Prev Cardiol 2005;8:87–92
   PubMedGoogle Scholar
• Yu T, Morita I, Shimokado K, et al. Amlodipine modulates THP-1cell adhesion to vascular endothelium via inhibition of protein kinase C signal transduction. Hypertension 2003;42:329–34
   PubMed Web of Science ®Google Scholar
• Messerli FH, Weir MR, Neutel JM. Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting. Am J Hypertens 2002;15:550–6
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Dell’Omo G, Melillo E, Mariani M. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension 2000;35:621–5
   PubMed Web of Science ®Google Scholar
• Lund-Johansen P, Stranden E, Helberg S, et al. Quantification of leg edema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 2003;21:1003–10
   PubMed Web of Science ®Google Scholar
• Lu J, Li LM, Cao WH, et al. Postmarketing surveillance on benazepril. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:412–16 (Chinese)
   PubMedGoogle Scholar
• Mohler ER III, Herrington D, Ouyang P, et al. A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure. J Clin Hypertens(Greenwich) 2006;8:692–8
   PubMedGoogle Scholar
• Neutel JM, Smith DH, Weber MA, et al. Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the systolic evaluation of Lotrel efficacy and comparative therapies (SELECT) study. J Clin Hypertens (Greenwich) 2005;7:641–6
   PubMedGoogle Scholar
• Bahl VK, Jadhav UM, Thacker HP. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice results from the STRONG prospective, observational, multicenter study. Am J Cardiovasc Drugs 2009;9:135–42
   PubMed Web of Science ®Google Scholar
• Dicpingaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129:169s–73s
   PubMed Web of Science ®Google Scholar